Drugs / Modified Xiao-Feng Powder
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04967092 Comparator | Aug 2021 → Mar 2023 | chronic urticaria | Prof. Lin Zhixiu | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Modified Xiao-Feng Powder | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04967092 ↗ |
| Known as | mXFP | “This study used modified Xiao-Feng Powder (mXFP) to evaluate the effectiveness and safety of mXFP in treating CU.” NCT04967092 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Xiao-Feng Powder (XFP, meaning Wind-Dispersing Powder), is reported to be one of the most frequently used Chinese herbal formulae for CU.” PMID 35869554 ↗ Jul 2022 |